OakChart

Perrigo Company plc

PRGOHealthcare·Drug Manufacturers - Specialty & Generic·USA·Mid·NYSE·Nov 11 • 10:09 AM ET

16.51-0.32 (-1.90%)
2026-11-11 16:10 CET
Market cap
2,336.04 USD m
Revenue, TTM
4,090.40 USD m
Net income, TTM
-1,769.70 USD m
Free cash flow, TTM
168.20 USD m
EPS diluted, TTM
-12.76
P/E
-
Compare

Price

PRGO against its 20, 50 and 200-day averages
2050200beatmiss
10.0012.0014.0016.0011.2M22.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PRGOclose 16.5120-day 16.1150-day 15.09200-day 12.5016.51

22.6% under 21.33 on 30 Oct 2025. Last 15 sessions, 12.6% high to low

Profile

PRGO
52-week range, 93% of the way up
9.2317.02

Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company was founded by Luther Perrigo in 1887 and is headquartered in Allegan, MI.

IndexRUT
Employees8100
IPODec 17, 1991
Beta0.68
ATR, 14d0.72
Rel volume0.24
Short float17.81%
Insider own0.44%
Inst own109.32%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.29B
Enterprise Value5.31B
Income-1.77B
Sales4.09B
Book/sh17.58
Cash/sh3.15
Dividend Est.1.16 (7.03%)
Dividend TTM1.16 (7.03%)
Dividend Ex-DateNov 27, 2026
Dividend Gr. 3/5Y3.71% 5.21%
Payout-
Employees8100
IPODec 17, 1991

Ratios

P/E-
Forward P/E7.14
PEG-
P/S0.56
P/B0.94
P/C5.25
P/FCF13.62
EV/EBITDA8.61
EV/Sales1.30
Quick Ratio1.36
Current Ratio2.35
Debt/Eq1.42
LT Debt/Eq1.40
Option/ShortYes / Yes

Earnings

EPS (ttm)-12.76
EPS next Y2.31
EPS next Q0.82
EPS this Y-16.85%
EPS next Y1.17%
EPS next 5Y-4.84%
EPS past 3/5Y-114.32% -53.83%
Sales past 3/5Y-1.50% 0.80%
EPS Y/Y TTM-3289.03%
Sales Y/Y TTM-4.45%
EPS Q/Q-465.37%
Sales Q/Q-5.22%
EarningsNov 04 BMO
EPS/Sales Surpr.17.49% 0.39%

Ownership

Insider Own0.44%
Insider Trans0.00%
Inst Own109.32%
Inst Trans-0.47%
ROA-19.70%
ROE-50.25%
ROIC-30.22%
Gross Margin32.38%
Oper. Margin4.56%
Profit Margin-43.26%
SMA202.49%
SMA509.39%
SMA20032.10%
Trades-

Technical

Shs Outstand138.80M
Shs Float138.19M
Short Float17.81%
Short Ratio9.39
Short Interest24.61M
52W High17.02 -3.00%
52W Low9.23 78.97%
Volatility6.88% 4.40%
ATR (14)0.72
RSI (14)60.44
Beta0.68
Rel Volume0.24
Avg Volume2.62M
Volume92,964

Performance

Perf Week4.30%
Perf Month7.42%
Perf Quarter28.68%
Perf Half Y51.33%
Perf YTD18.61%
Perf Year15.45%
Perf 3Y-41.87%
Perf 5Y-61.87%
Perf 10Y-81.51%
Recom2.60
Target Price17.00
Prev Close16.83
Price16.51
Change %-1.90%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 06, 2025DowngradeJJP MorganOverweight → Neutral$20+21.1%
Jan 14, 2025DowngradeAArgusBuy → Hold
Jan 06, 2025DowngradePPiper SandlerOverweight → Neutral$34 → $27+63.5%
Sep 24, 2024ResumedJJefferiesHold$50 → $30+81.7%
Nov 17, 2023InitiatedPPiper SandlerOverweight$37+124.1%
Mar 07, 2023InitiatedCCanaccord GenuityBuy$49+196.8%
Sep 14, 2022UpgradeAArgusHold → Buy$46+178.6%
Sep 06, 2022UpgradeWWells FargoEqual Weight → Overweight$48 → $54+227.1%
Oct 14, 2021UpgradeRRaymond JamesMkt Perform → Outperform$59+257.4%
Sep 30, 2021UpgradeJJefferiesHold → Buy$45 → $63+281.6%

Peers

Mkt cap
TickerCompanyMkt cap
PBHPrestige Consumer Healthcare Inc2.09B
HLNHaleon plc ADR39.82B
VTRSViatris Inc23.76B
TEVATeva- Pharmaceutical Industries Ltd49.59B
KVUEKenvue Inc37.09B
BLCOBausch + Lomb Corp7.54B
CHDChurch & Dwight Co Inc26.28B
ABTAbbott Laboratories189.96B
EPCEdgewell Personal Care Co1.33B
CLXClorox Co12.47B

Insider trading

latest 14 of 32
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Parker Geoffrey M.DirectorSep 11 '26Option Exercise13.661,26317,25334,480Sep 15 04:19 PM
Alford Bradley ADirectorSep 11 '26Option Exercise13.661,26317,25346,728Sep 15 04:18 PM
Ball DavidEVP & CBDOSep 09 '26Option Exercise14.347,701110,43214,448Sep 10 04:17 PM
Winterman Matthew JohnEVP, Supply, Ops, StrategyJul 08 '26Option Exercise10.5217,503184,13215,660Jul 09 02:00 PM
Khoury RobertoEVP and President of CSCIJul 08 '26Option Exercise10.527377,75314,498Jul 09 01:41 PM
Parker Geoffrey M.DirectorJun 12 '26Option Exercise10.9997610,72633,686Jun 16 04:54 PM
Alford Bradley ADirectorJun 12 '26Option Exercise10.9997610,72645,934Jun 16 04:36 PM
Lockwood-Taylor PatrickFormer CEO and directorJun 05 '26Option Exercise10.8325,230273,241136,076Jun 09 09:23 AM
Khoury RobertoEVP and President of CSCIJun 05 '26Option Exercise10.8317,902193,87917,433Jun 08 04:17 PM
Willis RobertEVP & CHROJun 05 '26Option Exercise10.833,44137,26652,365Jun 08 04:02 PM
Lennox AbigailEVP and CSOJun 05 '26Option Exercise10.833,82341,4036,603Jun 08 03:58 PM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerJun 05 '26Option Exercise10.839,17599,36586,935Jun 08 03:54 PM
Ball DavidEVP & CBDOJun 05 '26Option Exercise10.832,86731,0507,784Jun 08 03:49 PM
Atkinson CharlesEVP, General Counsel & Sec.Jun 05 '26Option Exercise10.836,69072,4537,690Jun 08 03:40 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
PEYInvesco High Yield Equity Dividend Achievers ETFAUM: 1.17B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B

News

latest 14 of 103
  • Perrigo to Attend the Jefferies Miami Consumer Conference (PR Newswire)
  • Perrigo's Tax-Aided Beat Masks Its First Core Guidance Cut Of The Year As The Infant Formula Exit Reshapes The Story (Earnings Whispers)
  • Perrigo: Q3 Earnings Snapshot (Associated Press)
  • Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations (PR Newswire)
  • Perrigo exits infant-formula with sale to MeridianMade (Just Food)
  • Loading…
  • Perrigo Announces Quarterly Dividend (PR Newswire)
  • Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade (PR Newswire)
  • Perrigo's Rally Meets Its Test As Q3 Must Prove The OTC Demand Turn Is Real (Earnings Whispers)
  • Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026 (PR Newswire)
  • Perrigo to Attend the Barclays Global Consumer Conference (PR Newswire)
  • Perrigo Co PLC (PRGO) (Q2 2026) Earnings Call Highlights: Market Share Gains Amidst Sales Decline (GuruFocus.com) +23.10% -5.50%
  • Perrigo: Q2 Earnings Snapshot (Associated Press)
  • Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.6000.511-0.100988.6984.82
2026Q22026-08-050.5000.3880.5341,0231,0163
2026Q12026-05-060.4300.307-2.874969.21,0353
2025Q42026-02-260.7700.784-10.2241,1101,1023
2025Q32025-11-050.8000.7540.0541,0431,0963
2025Q22025-08-060.5700.595-0.0611,0561,0833
2025Q12025-05-070.6000.566-0.0471,0441,0874
2024Q42025-02-270.9300.924-0.3231,1381,1954
2024Q32024-11-060.8100.812-0.1281,0881,1224
2024Q22024-08-020.5300.474-0.7711,0661,0983
2024Q12024-05-070.2900.2350.0301,0821,0933
2023Q42024-02-270.8600.830-0.2381,1571,1753
2023Q32023-11-070.6400.6260.1131,1241,2002
2023Q22023-08-080.6300.5110.0651,1931,1812
2023Q12023-05-090.4500.430-0.0081,1821,1722
2022Q42023-02-270.7500.705-0.1661,1551,2012

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY4.0304.0291.0704,8234,800
2020FY4.0204.099-1.1955,0635,093
2021FY2.0602.030-0.8714,1394,133
2022FY2.0702.040-1.0454,4524,512
2023FY2.5802.565-0.0944,6564,674
2024FY2.5702.560-1.2504,3734,430
2025FY2.7502.772-10.2904,2534,246
2026FY-2.287--3,992
2027FY-2.313--3,902
2028FY-2.370--3,790
2029FY-2.810--4,081
2030FY-2.900--4,107

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-042021,0119731,049
2026Q4S2026-10-292001,0691,0671,070
2026Q4S2026-10-282001,0691,0681,070
2026Q4S2026-10-203001,0681,0671,070
2026Q4S2026-10-123001,0711,0671,078
2026Q4S2026-08-123101,0711,0671,078
2026Q4S2026-08-053101,0711,0681,078
2026Q4S2026-08-043101,0751,0671,088
2026Q4S2026-07-293101,0751,0681,088
2026Q4S2026-07-203001,0681,0461,088
2026Q4S2026-07-153111,0681,0461,088
2026Q4S2026-06-083121,0681,0461,088
2026Q4S2026-06-053121,0681,0461,088
2026Q4S2026-05-063121,0681,0461,088

Estimate history

EPS, annual0.840.9471.07-1.195-0.871-1.045-0.094-1.25-10.292-12.7617
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.128-0.323-0.047-0.0610.054-10.224-2.8740.534-0.197
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual4944.54731.248374087.94141.24450.54655.14373.74253.24090.4
Period201720182019202020212022202320242025TTM
Sales, quarterly1088.11137.410441056.31043.11109.9969.11022.8988.6
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual140.8135.9136.1133.1133.8134.7135.5136.5137.6138.8
Period201720182019202020212022202320242025MRQ
Shares, quarterly136.5136.5137.2137.6137.6137.6138.1138.7138.8
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue4,090.404,253.204,373.704,655.104,450.504,141.204,087.904,837.004,731.20
Cost of Goods Sold Incl. D&A2,765.902,757.902,830.802,975.802,991.202,723.802,596.203,062.702,902.10
Gross Profit1,324.501,495.301,542.901,679.301,459.301,417.401,491.701,774.301,829.10
Selling, General and Administrative Excl. Other1,137.901,151.201,224.801,397.101,286.301,192.601,230.801,337.901,344.40
Research and Development92.0095.40112.20122.50123.10122.00121.70187.40218.60
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income186.60344.10318.10282.20173.00224.80260.90436.40484.70
Interest Expense204.70216.00248.50224.70145.30120.50135.80126.50120.30
Unusual Expense1,770.401,397.80173.1097.30140.40177.607.70250.30237.80
Net Income Before Taxes-1,652.90-1,297.90-80.70-8.30-139.10258.705.90171.00290.60
Income Taxes77.20104.4080.00-3.90-8.20389.60-38.3024.90159.60
Consolidated Net Income-1,730.20-1,402.30-160.70-4.40-130.90-130.9044.20146.10131.00
Net Income From Continuing Operations-1,730.20-1,402.30-160.70-4.40-130.90-130.9044.20146.10131.00
Net Income-1,769.70-1,425.40-171.80-12.70-140.60-116.40-162.60146.10131.00
EPS (Recurring)-3.81-3.23-0.370.41-0.310.06-1.162.352.15
EPS (Basic, Before Extraordinaries)-12.76-10.29-1.25-0.09-1.05-0.87-1.191.070.95
EPS (Diluted)-12.76-10.29-1.25-0.09-1.05-0.87-1.191.070.95
EBITDA616.70681.60644.00641.70511.60537.00645.70832.90908.30
Non-Operating Income (Expense)135.60-28.2022.8031.50-26.40332.00-111.50111.40164.00
Other After Tax Adjustments-0.100.000.000.000.000.000.000.000.00
Stock Option Compensation Expense34.4443.1350.8854.3543.3741.6142.7038.1129.78
Price To Earnings Ratio---10,056.25---48.3041.40
Price To Sales Ratio0.530.450.810.941.031.251.491.461.13
Gross Margin32.3835.1635.2836.0732.7934.2336.4936.6838.66
Operating Margin4.568.097.276.063.895.436.389.0210.24
Net Margin-43.26-33.51-3.93-0.27-3.16-2.81-3.983.022.77
Shares Outstanding138.80137.60136.50135.50134.70133.80133.10136.10135.90
Market Capitalization2,336.042,336.043,507.564,360.584,589.885,203.816,103.887,031.445,264.46

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue988.601,022.80969.101,109.901,043.101,056.301,044.001,137.40
Cost of Goods Sold Incl. D&A667.60708.50643.00746.80665.60693.50652.10752.90
Gross Profit321.00314.30326.10363.10377.50362.80391.90384.50
Selling, General and Administrative Excl. Other293.60274.90291.90277.50270.60295.10307.90262.60
Research and Development21.9023.7024.6021.8024.9022.0026.7027.90
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income27.4039.4034.2085.60106.9067.7084.00121.90
Interest Expense51.9047.2050.2055.4054.0053.5053.1043.10
Unusual Expense-5.7026.10396.801,353.2021.401.1018.4043.60
Net Income Before Taxes-18.10105.40-408.50-1,331.7022.403.208.3070.20
Income Taxes-3.8016.90-18.7082.809.703.708.20111.60
Consolidated Net Income-14.3088.50-389.90-1,414.5012.70-0.500.10-41.40
Net Income From Continuing Operations-14.3088.50-389.90-1,414.5012.70-0.500.10-41.40
Net Income-27.5074.50-398.60-1,418.107.50-8.40-6.40-44.50
EPS (Recurring)-0.230.66-0.87-3.390.16-0.060.05-0.10
EPS (Basic, Before Extraordinaries)-0.200.54-2.87-10.220.05-0.06-0.05-0.32
EPS (Diluted)-0.200.53-2.87-10.220.05-0.06-0.05-0.32
EBITDA109.20218.50117.50171.50192.30154.00163.90203.00
Non-Operating Income (Expense)0.60139.404.30-8.70-9.10-9.90-4.2050.40
Other After Tax Adjustments0.000.00-0.100.000.000.000.000.00
Stock Option Compensation Expense7.985.3711.389.7210.9813.279.166.95
Price To Sales Ratio0.530.340.320.450.700.850.890.81
Gross Margin32.4730.7333.6532.7136.1934.3537.5433.81
Operating Margin2.773.853.537.7110.256.418.0510.72
Net Margin-2.787.28-41.13-127.770.72-0.80-0.61-3.91
Shares Outstanding138.80138.70138.10137.60137.60137.60137.20136.50
Market Capitalization2,336.041,437.641,478.351,915.733,063.973,673.393,826.313,507.56

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments531.60558.80751.40600.801,865.30634.00360.90560.50695.70
Short Term Receivables650.10686.20768.10738.60693.10613.201,269.501,098.601,130.80
Inventories1,149.001,081.801,140.901,150.301,020.201,059.40967.30878.00806.90
Other Current Assets466.70155.10172.50230.20281.30826.90159.20365.10186.20
Total Current Assets2,797.402,481.902,832.902,719.903,859.903,133.502,756.902,902.202,819.60
Net Property, Plant & Equipment1,078.001,104.701,113.701,143.401,031.001,019.301,032.70829.10833.10
Total Investments and Advances25.4081.6092.30209.4069.5078.5020.1019.5011.20
Intangible Assets4,406.205,749.106,515.206,779.205,150.805,584.207,106.706,888.007,556.20
Deferred Tax Assets3.305.1025.807.106.5040.605.401.2010.40
Other Assets224.90225.30229.20158.30308.001,632.30379.60343.40398.30
Total Assets8,535.209,647.7010,809.1011,017.3010,425.7011,488.4011,301.4010,983.4011,628.80
Short Term Debt Incl. Current Port. of LT Debt62.3064.20468.1064.60629.8065.6035.40190.2070.40
Accounts Payable474.50495.20477.70537.30411.20451.60520.20474.90450.20
Income Tax Payable20.8017.4042.1014.4016.509.0032.2096.50116.10
Other Current Liabilities455.30467.40598.40497.30530.40855.80748.00775.80799.30
Total Current Liabilities1,012.901,044.201,586.301,113.601,587.901,382.001,335.801,537.401,436.00
Long Term Debt3,755.103,735.503,792.404,259.903,064.003,660.103,467.503,052.203,270.80
Provision for Risks Charges27.4027.4030.300.000.000.0037.3032.4058.40
Deferred Tax Liabilities168.90203.20262.30368.20239.30276.20280.60282.30321.90
Other Liabilities635.40318.00369.90433.50382.80515.00376.10411.00371.10
Total Liabilities5,599.705,328.306,041.206,175.205,274.005,833.305,497.305,315.305,458.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2,935.504,319.404,767.904,842.105,151.705,655.105,803.805,668.006,170.50
Total Shareholders Equity2,935.504,319.404,767.904,842.105,151.705,655.105,803.805,668.006,170.50
Accumulated Minority Interest0.000.000.000.000.000.000.300.100.10
Total Equity2,935.504,319.404,767.904,842.105,151.705,655.105,804.105,668.106,170.60
Total Liabilities & Stockholders Equity8,535.209,647.7010,809.1011,017.3010,425.7011,488.4011,301.4010,983.4011,628.80
Book Value Per Share21.3331.6435.1935.9538.5042.4942.6441.7143.82
Tangible Book Value Per Share-10.69-10.47-12.90-14.380.010.53-9.57-8.98-9.84
Full-Time Employees8,1008,3799,1408,9009,90011,50011,20010,60010,400
Price to Book Ratio0.960.770.921.001.011.051.210.932.03
Return on Assets-15.42-1.57-0.04-1.22-1.190.391.311.160.94
Return on Equity-38.66-3.54-0.09-2.62-2.420.772.552.211.97
Return on Invested Capital-21.30-2.13-0.15-1.54-1.42-1.751.581.501.27
Quick Ratio1.631.341.071.411.791.501.341.321.40
Current Ratio2.762.381.792.442.432.272.061.891.96

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-1,769.70-1,425.40-171.80-12.70-140.60-68.90-162.60146.10131.00
Depreciation346.80337.50325.90359.50338.60312.20384.80396.50423.60
Other Funds (Non Cash)1,681.901,478.30273.70223.80139.80199.00537.70202.6075.70
Funds from Operations202.90339.60437.60464.00287.30451.70705.40701.30612.40
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital37.70-101.10-74.70-58.5020.00-295.40-69.20-313.50-19.40
Income Taxes Payable74.0055.90-31.80-12.90-47.90-47.70-7.00-74.5068.10
Cash from Operating Activities240.60238.50362.90405.50307.30156.30636.20387.80593.00
Capital Expenditures-72.40-94.90-131.60-101.70-96.40-222.70-205.60-286.80-138.20
Net Assets From Acquisitions0.000.000.000.00-2,011.400.00-168.50-747.700.00
Sale of Fixed Assets and Businesses366.3014.40253.400.0058.701,491.90187.80182.505.20
Purchase or Sale of Investments0.000.000.000.000.000.00-15.000.00-7.50
Purchase of Investments0.000.000.000.000.000.00-15.000.00-7.50
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-0.10-0.50-48.200.000.000.000.000.000.00
Other Sources5.105.605.2024.2090.506.6013.50255.9013.70
Cash from Investing Activities298.90-75.4078.80-77.50-1,958.601,275.80-187.80-596.10-126.80
Cash Dividends Paid-160.20-159.30-152.50-149.70-142.40-129.60-123.90-112.40-104.90
Change in Capital Stock0.000.000.000.000.000.00-164.200.90-398.70
Repurchase of Common Pref Stock0.000.000.000.000.000.00-164.200.00-400.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.901.30
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.901.30
Issuance or Reduction of Debt, Net-348.40-34.80-442.50-30.20583.60-30.60143.20123.50-58.30
Change in Long Term Debt-348.40-34.80-442.50-30.20595.300.00147.10123.00-53.90
Issuance of Long Term Debt422.100.001,086.50295.101,554.200.00737.10599.00428.60
Reduction of Long Term Debt-770.50-34.80-1,529.00-325.30-958.900.00-590.00-476.00-482.50
Net Financing Active Other Cash Flow-23.60-26.40-16.00-7.30-19.60-18.50-36.20-10.20-10.00
Other Financing Activities Uses-23.60-26.40-16.00-7.30-19.60-18.50-36.20-10.20-10.00
Cash from Financing Activities-532.10-220.50-611.00-187.20421.60-178.70-181.101.80-571.90
Exchange Rate Effect-5.2032.50-23.209.80-48.90-15.6019.909.70-21.90
Net Change in Cash2.20-24.90-192.50150.60-1,278.601,237.80287.20-196.80-127.60
Free Cash Flow168.20145.10244.60303.80210.904.20465.80250.10490.40
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow268.69-38.3628.2566.94-17.8051.2113.90
Deferred Taxes & Investment Tax Credit--50.809.80-106.60-50.509.40-54.50-43.90-17.90

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments436.60399.70357.20531.60432.10454.20
Short Term Receivables718.20750.00732.80650.10675.60706.60
Inventories1,013.801,064.501,121.401,149.001,227.001,215.50
Other Current Assets233.40237.60501.10466.70544.50238.70
Total Current Assets2,402.002,451.702,712.402,797.402,879.202,615.00
Net Property, Plant & Equipment976.501,005.001,040.001,078.001,083.701,097.70
Total Investments and Advances31.5024.1027.2025.4059.9061.30
Intangible Assets3,834.003,887.803,965.704,406.205,765.906,042.70
Deferred Tax Assets6.506.304.703.3064.2048.10
Other Assets234.40234.60233.30224.90231.10229.30
Total Assets7,484.907,609.507,983.308,535.2010,084.0010,094.10
Short Term Debt Incl. Current Port. of LT Debt37.3036.8037.5062.3065.0065.30
Accounts Payable390.50400.40434.80474.50469.70489.00
Income Tax Payable37.1028.8028.6020.805.9010.30
Other Current Liabilities555.50588.80496.70455.30604.70561.50
Total Current Liabilities1,020.401,054.80997.601,012.901,145.301,126.10
Long Term Debt3,416.203,421.903,767.803,755.103,761.203,767.80
Provision for Risks Charges0.000.000.0027.400.000.00
Deferred Tax Liabilities141.30146.70153.50168.90194.40206.80
Other Liabilities466.60470.30565.60635.40536.60521.10
Total Liabilities5,044.505,093.705,484.505,599.705,637.505,621.80
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2,440.402,515.802,498.802,935.504,446.504,472.30
Total Shareholders Equity2,440.402,515.802,498.802,935.504,446.504,472.30
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2,440.402,515.802,498.802,935.504,446.504,472.30
Total Liabilities & Stockholders Equity7,484.907,609.507,983.308,535.2010,084.0010,094.10
Book Value Per Share17.5818.1418.0921.3332.3132.50
Tangible Book Value Per Share-10.04-9.89-10.62-10.69-9.59-11.41
Full-Time Employees---8,100--
Price to Book Ratio0.960.570.500.430.690.84
Return on Assets-19.70-19.24-20.20-15.42-0.27-0.58
Return on Equity-50.25-48.75-52.23-38.66-0.65-1.32
Return on Invested Capital-0.471.25-6.36-21.200.09-0.10
Quick Ratio1.361.321.591.631.441.24
Current Ratio2.352.322.722.762.512.32

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-27.5074.50-398.60-1,418.107.50-8.40
Depreciation81.8095.8083.3085.9085.4086.30
Other Funds (Non Cash)2.70-117.30410.901,385.6027.7023.50
Funds from Operations57.0046.6082.7016.6097.00114.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital39.2036.00-196.30158.80-45.30-38.20
Income Taxes Payable-19.90-0.20-13.20107.303.10-58.10
Cash from Operating Activities96.2082.60-113.60175.4051.7075.90
Capital Expenditures-17.50-14.30-13.80-26.80-21.90-19.20
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses3.40362.900.000.000.0014.40
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.00-0.100.000.00
Other Sources0.500.801.402.400.501.00
Cash from Investing Activities-13.60349.40-12.40-24.50-21.40-3.80
Cash Dividends Paid-40.20-40.20-39.90-39.90-39.90-38.90
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-2.50-335.00-2.20-8.70-8.50-8.80
Change in Long Term Debt-2.50-335.00-2.20-8.70-8.50-8.80
Issuance of Long Term Debt0.000.00422.100.000.000.00
Reduction of Long Term Debt-2.50-335.00-424.30-8.70-8.50-8.80
Net Financing Active Other Cash Flow-0.90-13.60-3.30-5.80-1.90-6.30
Other Financing Activities Uses-0.90-13.60-3.30-5.80-1.90-6.30
Cash from Financing Activities-43.50-388.90-45.30-54.40-50.30-54.00
Exchange Rate Effect-2.10-3.00-3.103.000.2019.00
Net Change in Cash37.0040.10-174.4099.50-19.8037.10
Free Cash Flow78.7068.30-127.40148.6029.8056.70
Price to Free Cash Flow268.69---26.5136.68

Revenue breakdown

Consolidation, Policy2024: 100.00K 2025: 200.00K
Digestive Health2024: 533.90M 2025: 482.40M
Healthy Lifestyle2024: 532.60M 2025: 547.90M
Nutrition2024: 449.50M 2025: 408.50M
Oral Care2024: 374.80M 2025: 354.40M
Other CSCA2024: 3.10M 2025: 4.80M
Other CSCI2024: 97.30M 2025: 62.40M
Pain and Sleep-aids2024: 567.70M 2025: 567.90M
Skincare and Personal Hygiene2024: 630.10M 2025: 622.60M
Upper Respiratory2024: 782.40M 2025: 817.70M
Vitamins, Minerals and Supplements2024: 188.00M 2025: 168.40M
Women's Health2024: 213.90M 2025: 215.90M
Europe2024: 1.60B 2025: 1.62B
Other countries2024: 119.50M 2025: 96.70M
United States2024: 2.65B 2025: 2.54B
Consolidation, Policy2024: 100.00K 2025: 100.00K
Consumer Self-Care Americas2024: 2.69B 2025: 2.59B
Consumer Self-Care International2024: 1.68B 2025: 1.67B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3017.81%24.6M138.2M2.72M
2026-10-1517.50%24.2M138.2M2.82M
2026-09-3017.55%24.2M138.2M2.91M
2026-09-1516.39%22.6M138.2M3.21M
2026-08-3116.33%22.6M138.2M3.40M
2026-08-1416.05%22.2M138.2M3.41M
2026-07-3116.75%23.1M138.2M3.32M
2026-07-1516.65%22.9M137.8M3.20M
2026-06-3017.84%24.6M137.8M3.27M
2026-06-1512.76%17.6M137.7M3.02M
2026-05-2910.94%15.1M137.8M3.19M
2026-05-1510.48%14.4M137.8M3.33M
2026-04-309.79%13.5M137.8M3.24M
2026-04-1510.15%13.9M137.1M3.32M
2026-03-3112.18%16.7M137.0M3.20M
2026-03-1311.52%15.8M137.0M3.46M
2026-02-2712.53%17.2M137.0M3.23M
2026-02-1311.09%15.2M137.0M3.34M
2026-01-3011.57%15.8M137.0M3.81M
2026-01-1510.19%13.9M136.9M3.68M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5012.9015.6011.8417.7940.000.000.991-0.0140.001
call5.0010.4012.8010.809.1952.000.000.987-0.0140.001
call7.507.0010.700.007.2750.000.000.981-0.0140.001
call10.004.608.705.506.20736.000.000.972-0.0130.002
call12.502.404.804.392.6083310.000.956-0.0120.002
call15.001.501.751.800.8254,4759.000.673-0.1020.009
call17.500.100.350.210.7261,4361.000.373-0.0540.010
call20.000.000.150.150.9764920.000.126-0.0290.005
call22.500.000.750.101.3958.000.000.096-0.0340.004
call25.000.000.950.001.7300.000.000.081-0.0370.004
put2.500.000.050.015.8551.000.00-0.007-0.0160.001
put5.000.002.150.273.8542.000.00-0.012-0.0170.001
put7.500.000.050.482.57880.000.00-0.017-0.0150.001
put10.000.000.050.031.7695,7140.00-0.026-0.0150.002
put12.500.000.050.051.0829030.00-0.039-0.0130.002
put15.000.051.400.132.0514,3470.00-0.330-0.1010.009
put17.500.803.101.882.4221000.00-0.607-0.0580.010
put20.001.854.603.902.5621.000.00-0.868-0.0270.006
put22.504.307.100.002.7080.000.00-0.902-0.0340.004
put25.007.609.400.002.9110.000.00-0.917-0.0370.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-26SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-27SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-29SCHEDULE 13G/ASEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-143Initial statement of beneficial ownership of securities2026-06-30SEC
2026-07-103Initial statement of beneficial ownership of securities2026-06-30SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-094Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-094Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-068-K/A2026-06-07SEC
2026-07-068-KCurrent report2026-06-29SEC
2026-06-308-KCurrent report2026-06-30SEC
2026-06-2411-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-11106.35K100

Institutional holders

Manager% owned
BlackRock, Inc.16.41%
Neuberger Berman Group LLC7.72%
VANGUARD PORTFOLIO MANAGEMENT LLC6.54%
PRICE T ROWE ASSOCIATES INC /MD/6.29%
STATE STREET CORP6.16%
FULLER & THALER ASSET MANAGEMENT, INC.5.42%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
FMR LLC4.50%
Invesco Ltd.4.24%
DIMENSIONAL FUND ADVISORS LP3.32%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.03%
Undiscovered Managers Behavioral Value Fund4.27%
T. Rowe Price Mid-Cap Value Fund, Inc.3.28%
iShares Russell 2000 ETF2.64%
ICON FLEXIBLE BOND FUND2.52%
High Yield Fixed Income Fund2.14%
Floating Rate Income Fund1.39%
Avantis U.S. Small Cap Value ETF1.32%
Fidelity Small Cap Index Fund1.12%
Federated Hermes MDT Small Cap Core Fund1.12%

OakChart. PRGO. Cached 15 minutes.